Primary regulatory

TRIUMPH-5: retatrutide compared with tirzepatide in adults with obesity.

ClinicalTrials.gov. TRIUMPH-5: retatrutide compared with tirzepatide in adults with obesity. NCT06662383.

ClinicalTrials.govAccessed 2026-07-12

Open original source

Registry record

Source metadata

Publisher: ClinicalTrials.gov
Source type: Primary regulatory
Registry ID: research-reta-11
Trial ID: NCT06662383
Source code: RETA-11

Source usage

Linked from 1 page

Compound

Retatrutide

Interpretation boundary

What this record can and cannot establish

Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.